Bristol myers squibb announces settlement of u.s. patent litigation for revlimid® (lenalidomide) with dr. reddy’s

New york--(business wire)---- $bmy--bristol myers squibb announces settlement of u.s. patent litigation for revlimid® (lenalidomide) with dr.

RDY Ratings Summary

RDY Quant Ranking